000 | 01229 a2200385 4500 | ||
---|---|---|---|
005 | 20250513031831.0 | ||
264 | 0 | _c19950905 | |
008 | 199509s 0 0 fre d | ||
022 | _a0007-4551 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDorval, T | |
245 | 0 | 0 |
_a[Immunotherapy of malignant diseases]. _h[electronic resource] |
260 |
_bBulletin du cancer _c1995 |
||
300 |
_a127s-138s p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aCytokines _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy _xmethods |
650 | 0 | 4 |
_aInterferons _xtherapeutic use |
650 | 0 | 4 |
_aInterleukin-2 _xtherapeutic use |
650 | 0 | 4 |
_aKidney Neoplasms _xtherapy |
650 | 0 | 4 |
_aLymphoproliferative Disorders _xtherapy |
650 | 0 | 4 |
_aMelanoma _xtherapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNeoplasms _ximmunology |
650 | 0 | 4 |
_aNeoplasms, Experimental _ximmunology |
650 | 0 | 4 |
_aNeuroblastoma _xtherapy |
700 | 1 | _aMichon, J | |
700 | 1 | _aTartour, E | |
700 | 1 | _aFridman, W H | |
773 | 0 |
_tBulletin du cancer _gvol. 82 Suppl 2 _gp. 127s-138s |
|
999 |
_c7542404 _d7542404 |